MS patients can safely get infusions at home, study finds

NCT ID NCT04777539

First seen May 02, 2026 · Last updated May 17, 2026 · Updated 3 times

Summary

This study looked at whether it is safe for people with multiple sclerosis to receive their natalizumab (Tysabri) infusions at home instead of at the hospital. Researchers followed 295 patients for one year, comparing serious side effects between home and hospital settings. The goal was to see if home treatment is just as safe and could improve quality of life.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS (MS) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • AP-HP La Pitié-Salpêtrière Hospital

    Paris, Paris, 75000, France

  • Adolphe de Rothschild Ophthalmological Foundation

    Paris, Paris, 75000, France

  • Bordeaux University Hospital

    Bordeaux, Gironde, 33000, France

  • Brest University Hospital

    Brest, Finistère, 29200, France

  • CH Ajaccio

    Ajaccio, France

  • CHU Grenoble Alpes

    La Tronche, 38700, France

  • Hôpital St Vincent de Paul

    Lille, 59020, France

  • Les Hôpitaux de Chartres

    Chartres, France

  • Libourne Hospital

    Libourne, Gironde, 33500, France

  • Lille University Hospital

    Lille, Nord, 59000, France

  • Marseille University Hospital

    Marseille, Bouches-du-Rhône, 13000, France

  • Nantes University Hospital

    Nantes, Loire-Atlantique, 44000, France

  • Orléans Hospital

    Orléans, Loiret, 45000, France

  • Percy Army Training Hospital

    Clamart, Hauts-de-Seine, 92140, France

  • Poitiers University Hospital

    Poitiers, Vienne, 86000, France

  • Rennes University Hospital

    Rennes, Ille-et-Vilaine, 35000, France

  • Rouen University Hospital

    Rouen, Seine-Maritime, 76000, France

  • Saint-Nazaire Hospital Center

    Saint-Nazaire, 44606, France

  • Strasbourg University Hospital

    Strasbourg, Bas-Rhin, 67000, France

  • Toulouse University Hospital

    Toulouse, Haute-Garonne, 31000, France

  • Tours University Hospital

    Tours, Indre-et-Loire, 37000, France

Conditions

Explore the condition pages connected to this study.